ICL Current Deferred Revenue from 2010 to 2024
| ICL Stock | USD 3.80 0.12 3.06% |
Current Deferred Revenue | First Reported 2009-12-31 | Previous Quarter 2 | Current Value 2 | Quarterly Volatility 132.8 M |
Check ICL Israel financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ICL Israel's main balance sheet or income statement drivers, such as Depreciation And Amortization of 619.6 M, Interest Expense of 120.4 M or Selling General Administrative of 379.1 M, as well as many indicators such as Price To Sales Ratio of 0.8, Dividend Yield of 0.0409 or PTB Ratio of 1.07. ICL financial statements analysis is a perfect complement when working with ICL Israel Valuation or Volatility modules.
ICL | Current Deferred Revenue |
Latest ICL Israel's Current Deferred Revenue Growth Pattern
Below is the plot of the Current Deferred Revenue of ICL Israel Chemicals over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. ICL Israel's Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ICL Israel's overall financial position and show how it may be relating to other accounts over time.
| Current Deferred Revenue | 10 Years Trend |
|
Current Deferred Revenue |
| Timeline |
ICL Current Deferred Revenue Regression Statistics
| Arithmetic Mean | 147,984,243 | |
| Geometric Mean | 69,308,514 | |
| Coefficient Of Variation | 141.40 | |
| Mean Deviation | 156,053,369 | |
| Median | 62,000,000 | |
| Standard Deviation | 209,253,739 | |
| Sample Variance | 43787.1T | |
| Range | 664.7M | |
| R-Value | (0.62) | |
| Mean Square Error | 28831.1T | |
| R-Squared | 0.39 | |
| Significance | 0.01 | |
| Slope | (29,167,935) | |
| Total Sum of Squares | 613019.8T |
ICL Current Deferred Revenue History
About ICL Israel Financial Statements
ICL Israel investors utilize fundamental indicators, such as Current Deferred Revenue, to predict how ICL Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 16.9 M | 16 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectAdditional Information and Resources on Investing in ICL Stock
When determining whether ICL Israel Chemicals is a strong investment it is important to analyze ICL Israel's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ICL Israel's future performance. For an informed investment choice regarding ICL Stock, refer to the following important reports:Check out the analysis of ICL Israel Correlation against competitors. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Fertilizers & Agricultural Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ICL Israel. If investors know ICL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ICL Israel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.29) | Dividend Share 0.201 | Earnings Share 0.33 | Revenue Per Share 5.458 | Quarterly Revenue Growth (0.06) |
The market value of ICL Israel Chemicals is measured differently than its book value, which is the value of ICL that is recorded on the company's balance sheet. Investors also form their own opinion of ICL Israel's value that differs from its market value or its book value, called intrinsic value, which is ICL Israel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ICL Israel's market value can be influenced by many factors that don't directly affect ICL Israel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ICL Israel's value and its price as these two are different measures arrived at by different means. Investors typically determine if ICL Israel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ICL Israel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.